These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 6333522)

  • 1. In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall.
    Goodhart GL
    JAMA; 1984 Nov; 252(19):2748-9. PubMed ID: 6333522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New applications of old antimicrobials.
    Marks MI
    Pediatr Ann; 1986 Jun; 15(6):434-5, 438-40. PubMed ID: 3523401
    [No Abstract]   [Full Text] [Related]  

  • 3. Trimethoprim-sulfamethoxazole.
    Rubin RH; Swartz MN
    N Engl J Med; 1980 Aug; 303(8):426-32. PubMed ID: 6967184
    [No Abstract]   [Full Text] [Related]  

  • 4. Trimethoprim-sulphamethoxazole in urinary tract infection due to Streptococcus faecalis.
    Chattopadhyay B
    J Clin Pathol; 1972 Jun; 25(6):531-3. PubMed ID: 4625437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

  • 6. Canine urinary tract infections: a comparison of in vitro antimicrobial susceptibility test results and response to oral therapy with ampicillin or with trimethoprim-sulfa.
    Ling GV; Rohrich PJ; Ruby AL; Johnson DL; Jang SS
    J Am Vet Med Assoc; 1984 Aug; 185(3):277-81. PubMed ID: 6332102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 8. Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection.
    Nguyen HT; Hurwitz RS; Defoor WR; Minevich E; McAdam AJ; Mortensen JE; Novak-Weekley SM; Minnillo BJ; Elder JS
    J Urol; 2010 Jul; 184(1):305-10. PubMed ID: 20488468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
    Crider SR; Colby SD
    Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections.
    Sabbaj J; Hoagland VL; Shih WJ
    Antimicrob Agents Chemother; 1985 Mar; 27(3):297-301. PubMed ID: 3158272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Listeria meningitis--in vitro sensitivities to co-trimoxazole, penicillins and gentamicin.
    Prichard MG; Miles HM; Pavillard ER
    Aust N Z J Med; 1983 Feb; 13(1):76-7. PubMed ID: 6411056
    [No Abstract]   [Full Text] [Related]  

  • 12. Trimethoprim/sulfonamide: rational combination therapy.
    Hitchings GH; Singleton SW
    Compr Ther; 1976 May; 2(5):55-63. PubMed ID: 776520
    [No Abstract]   [Full Text] [Related]  

  • 13. In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.
    Yeldandi V; Strodtman R; Lentino JR
    J Antimicrob Chemother; 1988 Dec; 22(6):873-80. PubMed ID: 3266621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of chemotherapeutics on the species streptococcus in vitro.
    Výmola F; Jedlicková Z
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(3):383-8. PubMed ID: 1102599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of changing selection pressures on trimethoprim resistance in Enterobacteriaceae.
    Towner KJ; Slack RC
    Eur J Clin Microbiol; 1986 Oct; 5(5):502-6. PubMed ID: 3490973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
    Wong CK; Harding GK; Ronald AR; Hoban S
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole].
    Riou B; Richard C; Rimailho A; Coquin Y; Rottman E; Auzepy P
    Ann Med Interne (Paris); 1985; 136(5):412-5. PubMed ID: 3904566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-trimoxazole and the thyroid.
    Smellie JM; Bantock HM; Thompson BD
    Lancet; 1982 Jul; 2(8289):96. PubMed ID: 6123827
    [No Abstract]   [Full Text] [Related]  

  • 19. Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy.
    Sattler FR; Remington JS
    Eur J Clin Microbiol; 1984 Jun; 3(3):174-6. PubMed ID: 6332015
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness and tolerance of norfloxacin compared with trimethoprim-sulfamethoxazole in the treatment of uncomplicated urinary tract infections].
    Ballesteros JJ; Salvador M; Macías J; Honorato J; Rubio A; Azanza JR
    Rev Med Univ Navarra; 1988; 32(3):135-7. PubMed ID: 3070683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.